CHINA TIAN YUAN HEALTHCARE GROUP LIMITED Financials China Tian Yuan Healthcare Group Limited
Equities
557
KYG8442J1004
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.87 HKD | 0.00% |
|
0.00% | +70.59% |
Valuation
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 1,197 | 410.9 | 287.3 | 678.3 | 387 | 498.7 |
| Enterprise Value (EV) 1 | 1,088 | 342.8 | 255.7 | 662.3 | 368.8 | 518.2 |
| P/E ratio | 78.3 x | -14.9 x | -1.69 x | -10.4 x | -23 x | -17.2 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 6.83 x | 2.4 x | 4.07 x | 12 x | 4.09 x | 9.2 x |
| EV / Revenue | 6.21 x | 2 x | 3.62 x | 11.8 x | 3.9 x | 9.56 x |
| EV / EBITDA | -134 x | -26.5 x | -4.24 x | -24.8 x | -28.3 x | -27.8 x |
| EV / FCF | -7.73 x | -3.8 x | -9.63 x | 5.4 x | 35.6 x | -28.7 x |
| FCF Yield | -12.9% | -26.3% | -10.4% | 18.5% | 2.81% | -3.48% |
| Price to Book | 2.45 x | 0.85 x | 0.91 x | 2.54 x | 1.51 x | 2.22 x |
| Nbr of stocks (in thousands) | 398,980 | 398,980 | 398,980 | 398,980 | 398,980 | 398,980 |
| Reference price 2 | 3.000 | 1.030 | 0.7200 | 1.700 | 0.9700 | 1.250 |
| Announcement Date | 4/30/18 | 4/30/19 | 8/23/20 | 6/6/21 | 4/28/22 | 4/28/23 |
1HKD in Million2HKD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales 1 | 175.3 | 171.6 | 70.55 | 56.34 | 94.59 | 54.22 |
| EBITDA 1 | -8.111 | -12.95 | -60.28 | -26.7 | -13.02 | -18.63 |
| EBIT 1 | -18.81 | -35.15 | -78.15 | -43.36 | -17.42 | -22.61 |
| Operating Margin | -10.73% | -20.49% | -110.77% | -76.96% | -18.42% | -41.7% |
| Earnings before Tax (EBT) 1 | 0.902 | -39.67 | -189.8 | -125.8 | -19.06 | -40.35 |
| Net income 1 | 14.88 | -27.62 | -170.2 | -65.1 | -16.85 | -29.04 |
| Net margin | 8.49% | -16.1% | -241.26% | -115.55% | -17.82% | -53.56% |
| EPS 2 | 0.0383 | -0.0692 | -0.4266 | -0.1632 | -0.0422 | -0.0728 |
| Free Cash Flow 1 | -140.8 | -90.19 | -26.54 | 122.6 | 10.37 | -18.06 |
| FCF margin | -80.32% | -52.57% | -37.62% | 217.66% | 10.96% | -33.3% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 4/30/18 | 4/30/19 | 8/23/20 | 6/6/21 | 4/28/22 | 4/28/23 |
1HKD in Million2HKD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | 19.5 |
| Net Cash position 1 | 109 | 68.2 | 31.6 | 16 | 18.2 | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | -1.048 x |
| Free Cash Flow 1 | -141 | -90.2 | -26.5 | 123 | 10.4 | -18.1 |
| ROE (net income / shareholders' equity) | -0.27% | -6.96% | -39% | -30.9% | -6.56% | -15.3% |
| ROA (Net income/ Total Assets) | -1.88% | -3.08% | -8.19% | -6.53% | -2.87% | -3.98% |
| Assets 1 | -790.6 | 895.5 | 2,077 | 997.7 | 586.3 | 729.5 |
| Book Value Per Share 2 | 1.220 | 1.220 | 0.7900 | 0.6700 | 0.6400 | 0.5600 |
| Cash Flow per Share 2 | 0.3400 | 0.2900 | 0.0600 | 0.1500 | 0.1600 | 0.0700 |
| Capex 1 | 18.5 | 2.41 | 1.41 | 0.34 | 1.46 | 1.35 |
| Capex / Sales | 10.55% | 1.4% | 2% | 0.6% | 1.54% | 2.49% |
| Announcement Date | 4/30/18 | 4/30/19 | 8/23/20 | 6/6/21 | 4/28/22 | 4/28/23 |
1HKD in Million2HKD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +70.59% | 44.34M | |
| -20.16% | 16.21B | |
| +4.50% | 12.44B | |
| +3.98% | 11.58B | |
| +9.72% | 10.79B | |
| +23.61% | 8.26B | |
| -2.19% | 7.68B | |
| +20.75% | 7.2B | |
| +4.49% | 6.67B | |
| +50.89% | 4.66B |
- Stock Market
- Equities
- 557 Stock
- Financials China Tian Yuan Healthcare Group Limited
